Guo Meng
Director/Board Member bij SSY GROUP LIMITED
Vermogen: 13 M $ op 31-03-2024
Profiel
Guo Meng is currently an Executive Director & Deputy General Manager at SSY Group Ltd., a Director at New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd., and a Director at Hebei Guolong Pharmaceutical Co., Ltd.
Previously, Mr. Meng served as the Executive President & Director at Shijiazhuang No.
4 Pharmaceutical Co., Ltd.
Mr. Meng's education includes an undergraduate degree from Lanzhou University and a graduate degree from Beijing University of Technology.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SSY GROUP LIMITED
0.67% | 30-06-2023 | 20 000 000 ( 0.67% ) | 13 M $ | 31-03-2024 |
Actieve functies van Guo Meng
| Bedrijven | Functie | Begin |
|---|---|---|
| SSY GROUP LIMITED | Director/Board Member | 27-08-2021 |
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
 New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The private company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Director/Board Member | - |
| Hebei Guolong Pharmaceutical Co., Ltd. | Director/Board Member | - |
Eerdere bekende functies van Guo Meng
| Bedrijven | Functie | Einde |
|---|---|---|
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
 Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | President | - |
Opleiding van Guo Meng
| Lanzhou University | Undergraduate Degree |
| Beijing University of Technology | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SSY GROUP LIMITED | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The private company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Finance |
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | Health Technology |
| Hebei Guolong Pharmaceutical Co., Ltd. |
